ENDOCYTE (ECYT) Covered Calls

Endocyte Inc is a biopharmaceutical Company developing targeted therapies for the treatment of cancer and inflammatory diseases. It uses its proprietary technology to create novel small molecule drug conjugates, or SMDCs, and companion imaging diagnose.

You can sell covered calls on ENDOCYTE to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ECYT (prices last updated Tue 4:16 PM ET):

ENDOCYTE (ECYT) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
14.15 -0.37 13.65 14.13 1.3M - 1.0B
Covered Calls For ENDOCYTE (ECYT)
Expiration Strike Call Bid Net Debit Return
If Flat
Annualized
Return If Flat
Jul 20 14 1.25 12.88 8.7% 99.2%
Aug 17 14 1.30 12.83 9.1% 55.4%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial


Extended Business Description

Endocyte, Inc. is a biopharmaceutical company, which develops targeted therapies for the treatment of cancer and inflammatory diseases. The company uses its proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. The company was founded by P. Ron Ellis and Philip S. Low on December 6, 1995 and is headquartered in West Lafayette, IN.